FibroBiologics, Inc. announced the closing of a registered direct offering, selling 3,540,000 shares of common stock and pre-funded warrants. The purchase price was paid in sovereign-issued gold coins valued at $4,069.18 per ounce. The Company also issued unregistered warrants in a concurrent private placement for up to 12,110,203 shares of common stock. The gross proceeds from the offering were approximately $4 million, with intentions to use the net proceeds for general corporate purposes and debt satisfaction. FibroBiologics holds 270+ patents and is focused on developing therapeutics for chronic diseases using fibroblasts.

Source: Globe Newswire

Read more at GlobeNewswire: FibroBiologics Announces Closing of $4 Million Registered